Top compounds associated with response to TTYH3


Feature Type Standardized
Nominal ANOVA
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.11 0.05
mRNA necrostatin-1 CTRPv2 pan-cancer AAC 0.082 0.05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.071 0.05
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.08 0.05
mRNA AZ628 GDSC1000 pan-cancer AAC 0.1 0.05
mRNA BRD-K96970199 CTRPv2 pan-cancer AAC 0.18 0.05
mRNA KU-55933 CTRPv2 pan-cancer AAC 0.08 0.05
mRNA NVP-231 CTRPv2 pan-cancer AAC 0.071 0.05
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.077 0.05
mRNA AZD4547 CTRPv2 pan-cancer AAC 0.082 0.05
Download CSV